STEPTOE LLP

Lobbying for AQUESTIVE THERAPEUTICS, INC. · Pharmaceutical

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · $20,000.00 income · posted Apr 21, 2025

Lobbying activity 2

Health Issues

Issues related to the FDA and the Orphan Drug Program.

Pharmacy

Issues related to the FDA and the Orphan Drug Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.